GB Sciences, Inc. (GBLX)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 03:49PM EDT
Loading interactive chart...
- ACCESSWIRE
Gb Sciences’ Novel Parkinson’s Disease Medication is Featured on Worldwide Business with kathy ireland(R)
Tune in this Sunday, Dec. 17, at 5:30 p.m. ET on the Fox Business Network to learn about Gb Sciences' cannabinoid-based medicine for the treatment of Parkinson's disease.LAS VEGAS, NV / ACCESSWIRE / December 14, 2023 / Gb Sciences, Inc. (OTCQB:GBLX), ...
- ACCESSWIRE
Gb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridge
Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, has successfully completed a dose response study in rodents at the University of Lethbridge that supports Gb Sciences' cannabinoid-based therapy for Parkinson's disease. The study has established dose ranges and the corresponding times to onset and duration of action in a rodent model.
© 2024 Yahoo. All rights reserved.